Deya is a Professor of Molecular Medicine, and a founding member of the Reproductive Biology and Gynaecological Oncology Group at Swansea University Medical School.
She considers herself a translational scientist in the areas of female infertility and cancer, with the ultimate goal of developing functional platforms and bringing targeted therapies into the clinic for the benefit of patients. Her projects involve close collaborations with the NHS and the private sector in the areas of multicellular 3D-patient derived models of disease and precision medicines including Antibody Drug Conjugates and Exosomes. She is a co-PI of the CEAT-Cluster for Epigenomics and ADC therapeutics project (£2.6M), where she leads the ADC programme.
Deya is also the Chair of Research Ethics & Governance at Swansea University Medical School. She serves as editorial member of several journals in the areas of reproductive medicine and oncology. Deya is the Regional non-clinical Champion for South West Wales within the Wales Cancer Research Centre.